Scientists hunt for clues to stop brain Cancer's return
NCT ID NCT07173829
First seen Jun 26, 2026 · Last updated Aug 07, 2026 · Updated 2 times
Summary
This study will analyze blood and tumor samples from 45 adults with glioblastoma to understand why this aggressive brain cancer recurs. Researchers will look at molecular, immune, and metabolic changes in tumors from both new and recurrent cases. The goal is to find new targets for better treatments, not to test a specific drug.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this research could reveal new targets for future treatments for glioblastoma, a deadly brain cancer.
- What could go wrong
- This is an observational study, not a treatment trial. It aims to gather knowledge, not test a therapy, so direct patient benefits are unlikely in the near term.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU de Bordeaux
RECRUITINGBordeaux, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New imaging clues could sharpen brain tumor monitoring
- Can a virus injected into brain tumors fight recurrence?
- Can a Tumor's genetic blueprint guide better treatment for kids with brain cancer?
- Can a seizure drug outsmart a deadly brain tumor?
- A simple lotion duo may shield skin from Tumor-Treating fields
- Can a One-Two punch slow recurrent brain cancer?